南极磷虾油事件后，同仁堂回应五大焦点问题

Core Viewpoint - The recent controversy surrounding the Antarctic krill oil product has prompted Tongrentang to take immediate action, including product recalls and legal proceedings against involved parties, to protect its brand reputation and ensure compliance with regulations [1][2]. Group 1: Company Actions - Tongrentang has initiated a comprehensive investigation into the brand usage across its subsidiaries and has mandated the immediate recall of the implicated Antarctic krill oil products [1][7]. - The company has filed lawsuits against Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd., Anhui Habao Pharmaceutical Co., Ltd., and related e-commerce platforms for trademark infringement and unfair competition [4][5]. - A task force has been established to monitor and rectify the production and sales channels of the implicated distributor, Sichuan Health, and to ensure compliance with brand management standards [7][11]. Group 2: Brand Management and Compliance - The brand authorization for Sichuan Health expired on November 30, 2021, and the company continued to use the Tongrentang brand without permission, leading to numerous complaints about unauthorized products [6][7]. - Tongrentang has emphasized that it prohibits any unauthorized use of its brand elements on non-company products and has been actively cleaning up violations of brand usage [8][9]. - The company is working to standardize the identification of authorized stores on e-commerce platforms and has provided a whitelist of official authorized stores on its website [10][11]. Group 3: Consumer Assurance - Consumers are encouraged to verify authorized Tongrentang stores through the official website to avoid purchasing unauthorized products [10]. - The company has committed to maintaining communication with regulatory bodies to address infringement issues and has taken legal action against persistent violators [11].